| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.15 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.16 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.15 | 0.5 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |